( OTC-BB:SNDC,OTC-BB:VOLN )

News from VolitionRX Limited A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Feb 06, 2015, 08:00 ET VolitionRx Limited Prices Public Offering of Common Stock

VolitionRx Limited (NYSE MKT: VNRX), a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types...


Nov 24, 2014, 08:00 ET VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014

VolitionRx Limited (OTCQB: VNRX), a life sciences company focused on developing diagnostic tests for cancer and other conditions, today announced...


Nov 05, 2014, 08:00 ET VolitionRx to Present at the SeeThruEquity Conference

VolitionRx Limited (OTCQB: VNRX), a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types and...


Oct 31, 2014, 08:00 ET VolitionRx Initiates Sponsorship of Two-time Cancer Survivor to Drive Awareness for the Importance of Early Cancer Detection

VolitionRx Limited (OTCQB: VNRX), a life sciences company focused on developing blood-based diagnostic tests, today announced...


Oct 02, 2014, 08:00 ET VolitionRx Announces Prostate Cancer Collaboration with the University of Texas MD Anderson Cancer Center

VolitionRx Limited (OTCQB: VNRX), a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today...


Sep 05, 2014, 06:30 ET VolitionRx to Present at the Aegis Capital Corp. 2014 Healthcare & Technology Conference

 VolitionRx Limited (OTCQB: VNRX), a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer...


Dec 02, 2013, 06:30 ET VolitionRx Finds Simple Blood Test Detects 85% of Colorectal Cancers and Over 50% of Polyps

 VolitionRx Limited (VNRX:OB), a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today...


Nov 29, 2013, 08:30 ET VolitionRx to Present at the 6th Annual LD Micro Conference

 VolitionRx Limited (VNRX:OB), a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today...


Nov 14, 2013, 06:30 ET VolitionRx Expands Sample Size to 11,000 in Pivotal Colorectal Cancer Trial with Hvidovre Hospital, Denmark

VolitionRx Limited (VNRX:OB), a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today...


Nov 07, 2013, 06:30 ET First VolitionRx Study Data Presented at CNAPS, Baltimore

 VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests for different types of...


Sep 26, 2013, 06:30 ET VolitionRx and Active Motif enter into Distribution Agreement for Volition's Research Use Only ELISA Kits

 VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests for different types of...


Sep 03, 2013, 06:30 ET VolitionRx-led Consortium Awarded euro 780 000 ($1M approx.) Eurostars Grant

 VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, is...


Jul 22, 2013, 06:30 ET VolitionRx to use Innova Biosciences' Biotin Technology in its Epigenetic Research Kits

VolitionRx Limited (OTC: VNRX), a life sciences company focused on the development of blood-based diagnostic tests, has signed a non-exclusive...


May 01, 2013, 06:30 ET Racepoint Group Appointed by VolitionRx to Raise Awareness of its new Early-Stage Cancer Diagnostic

VolitionRx Limited (OTC: VNRX), a life sciences company that is developing blood-based diagnostic tests for different types of cancer, has retained...


Apr 04, 2013, 06:30 ET VolitionRx Files Two Patent Applications

 VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests, announces that it has filed two...


Mar 26, 2013, 07:00 ET VolitionRx Hires Head of US Operations, Jason Terrell MD

VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests, announces that it has hired Jason...


Jan 09, 2013, 06:30 ET VolitionRx Announces Collaboration with Wales Cancer Bank

 VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests, announces that it will commence a...


Dec 17, 2012, 06:30 ET Volition Launches NuQ® Epigenetic Immunoassays for Research Use

 VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests, announces the launch of NuQ®,...


Nov 05, 2012, 06:30 ET VolitionRx's Preliminary Diagnostic Clinical Trial Results Show High Sensitivity and Specificity for Colon, Breast and Lung Cancers

 VolitionRx Limited (OTC: VNRX), a life sciences company focused on developing blood-based diagnostic tests, today announced preliminary...


Aug 21, 2012, 06:30 ET VolitionRX to Begin Prospective Clinical Trial in Colon Cancer

 VolitionRX Limited, a life sciences company focused on developing blood-based diagnostic tests, announces that its subsidiary Belgian Volition...


Jul 16, 2012, 06:30 ET VolitionRX Issues CEO Letter to Shareholders

 VolitionRX Limited (VNRX.OB), a life sciences company focused on developing blood-based diagnostic tests, issues the following letter to...


Jul 09, 2012, 06:30 ET VolitionRX Signs Collaboration Agreement With Stefan Holdenrieder of Rheinische Friedrich-Wilhelms-Universitat Bonn Germany

VolitionRX Limited (OTC:VNRX.OB), a life sciences company focused on developing blood-based diagnostic tests, is pleased to announce that it has...


May 14, 2012, 08:00 ET VolitionRX Raises Over $1 Million To Begin Clinical Trials of Blood Based Diagnostic Tests

 VolitionRX Limited (VNRX.OB), a life sciences company focused on developing blood-based diagnostic tests, is pleased to announce the closure...


Mar 27, 2012, 19:01 ET Pioneering New Science Nucleosomics Advances Blood Based Diagnostics for Cancer

The ability to diagnose disease early has long been a goal in the medical arena. VolitionRX (VNRX.OB), a life sciences company, is pioneering...


Feb 17, 2012, 05:00 ET Volition Signs Collaboration Agreement With Abcodia

 VolitionRX Limited (VNRX.OB), a life sciences company focused on developing blood-based diagnostic tests, announces a collaboration agreement...